Predicting chemotherapy response in locally advanced breast cancer
Part of Cancer, Skin clinical trials.
This study looks at how well certain breast cancers respond to chemotherapy given before surgery. If you join, you would receive the standard chemotherapy, and the researchers will use your tumor samples to see if they can predict how well it will work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have breast cancer confirmed by a biopsy.
- Your cancer must be 'locally advanced' – meaning it is large or has spread to nearby lymph nodes, but not to distant organs.
- Your cancer must not have spread to distant parts of the body (like bones, liver, or lungs).
- You must not have another type of cancer (besides the current breast cancer).
- You must be able to receive chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a computer model can predict if breast cancer will completely respond to chemotherapy before surgery. It is for people with early-stage breast cancer who are about to start neoadjuvant chemotherapy.
This study uses a sample of your tumor to grow a mini-tumor in the lab (called an organoid) to see which chemotherapy might work best for you. This could help reduce the chance of cancer coming back after treatment.
This trial tests whether we can predict how well hormone therapy works before surgery for early-stage breast cancer. It may help women with estrogen receptor-positive, HER2-negative or HER2-low breast cancer avoid or tailor treatments.
This trial tests a personalized approach to treating breast cancer that has spread to nearby lymph nodes. Your surgery and radiation will be tailored to how well your cancer responds to initial chemotherapy or hormone therapy.
This trial is studying tiny molecules in your blood (called microRNAs) to see if they can predict how well breast cancer responds to chemotherapy given before surgery. If you are starting neoadjuvant chemotherapy, this study may help personalize your treatment.
This trial compares two treatments for locally advanced breast cancer: chemotherapy before surgery plus radiation, versus chemotherapy before surgery alone. The goal is to see which approach works better for this specific type of cancer.
Hear when a new Locally Advanced Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.